METHOD FOR ASSESSING THE ADAPTEDNESS OF THE IMMUNE SYSTEM BY THE LEVEL OF HUMAN LYMPHOPROLIFERATION IN THE ARCTIC CONDITIONS Russian patent published in 2021 - IPC G01N33/48 

FIELD: medicine.

SUBSTANCE: invention relates to the field of physiology, immunology, laboratory diagnostics, pathophysiology, and is intended for assessing the adaptedness of the immune system by the level of human lymphoproliferation in the Arctic conditions. The concentration of CD10⁺ and CD71⁺ lymphocyte phenotypes is determined in the peripheral venous blood. If the values of the content of each of the groups of lymphocytes with CD10⁺ and CD71⁺ phenotypes are within the range of 0.50 to 0.60∙10⁹ cl/l, stable adaptedness of the immune system in the Arctic conditions is considered to be formed.

EFFECT: invention provides a possibility to conduct rapid screening diagnostics, reduce the time and simplify the methods for selecting persons with an adapted immune system by the level of lymphoproliferation in the Arctic conditions.

1 cl, 5 ex